(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.44%) $79.34
(-0.18%) $2.18
(-0.27%) $2 316.00
(-0.13%) $27.57
(0.07%) $985.30
(0.06%) $0.931
(0.17%) $10.91
(0.06%) $0.801
(0.00%) $91.74
4 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 0.00%
1.18% ¥ 4 814.00
Live Chart Being Loaded With Signals
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business...
Stats | |
---|---|
Dzisiejszy wolumen | 38 000.00 |
Średni wolumen | 294 471 |
Kapitalizacja rynkowa | 304.83B |
EPS | ¥0 ( 2024-02-08 ) |
Następna data zysków | ( ¥83.23 ) 2024-05-13 |
Last Dividend | ¥36.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 14.23 |
ATR14 | ¥5.91 (0.12%) |
Wolumen Korelacja
Suzuken Co., Ltd. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Suzuken Co., Ltd. Korelacja - Waluta/Towar
Suzuken Co., Ltd. Finanse
Annual | 2022 |
Przychody: | ¥2 314.83B |
Zysk brutto: | ¥179.70B (7.76 %) |
EPS: | ¥236.46 |
FY | 2022 |
Przychody: | ¥2 314.83B |
Zysk brutto: | ¥179.70B (7.76 %) |
EPS: | ¥236.46 |
FY | 2022 |
Przychody: | ¥2 232.77B |
Zysk brutto: | ¥160.99B (7.21 %) |
EPS: | ¥163.19 |
FY | 2021 |
Przychody: | ¥2 128.48B |
Zysk brutto: | ¥157.84B (7.42 %) |
EPS: | ¥88.52 |
Financial Reports:
No articles found.
Suzuken Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥36.00 (N/A) |
¥0 (N/A) |
¥36.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥9.09 | 2001-03-27 |
Last Dividend | ¥36.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥939.27 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.84 | -- |
Div. Sustainability Score | 6.61 | |
Div.Growth Potential Score | 2.58 | |
Div. Directional Score | 4.59 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
4187.T | Ex Dividend Knight | 2023-11-29 | Semi-Annually | 0 | 0.00% | |
3388.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2462.T | Ex Dividend Knight | 2023-11-29 | Semi-Annually | 0 | 0.00% | |
9404.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8068.T | Ex Dividend Knight | 2024-01-30 | Semi-Annually | 0 | 0.00% | |
7350.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6590.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
5936.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4617.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3852.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0117 | 1.500 | 9.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0212 | 1.200 | 9.29 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0664 | 1.500 | -0.373 | -0.560 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.186 | 0.800 | 9.07 | 7.26 | [1 - 3] |
quickRatioTTM | 0.954 | 0.800 | 9.10 | 7.28 | [0.8 - 2.5] |
cashRatioTTM | 0.206 | 1.500 | 9.97 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 807.19 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.0775 | 1.000 | -2.04 | -2.04 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0146 | 1.000 | -1.707 | -1.707 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.818 | 0.800 | 1.213 | 0.970 | [0.5 - 2] |
Total Score | 6.61 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.84 | 1.000 | 8.70 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0664 | 2.50 | -0.240 | -0.560 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.692 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -3.58 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00727 | 1.000 | -2.32 | 0 | [0.1 - 0.5] |
Total Score | 2.58 |
Suzuken Co., Ltd.
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej